Next Article in Journal
Genome-Wide Characterization and Functional Analysis of ABCG Subfamily Reveal Its Role in Cutin Formation in Cotton
Next Article in Special Issue
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation
Previous Article in Journal
Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
Previous Article in Special Issue
Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms
 
 
Review
Peer-Review Record

Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far

Int. J. Mol. Sci. 2023, 24(3), 2380; https://doi.org/10.3390/ijms24032380
by Myrtani Pieri 1,2, Panayiotis Vayianos 1, Vicky Nicolaidou 1,2, Kyriacos Felekkis 1,2,* and Christos Papaneophytou 1,2,*
Reviewer 1:
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2023, 24(3), 2380; https://doi.org/10.3390/ijms24032380
Submission received: 19 December 2022 / Revised: 9 January 2023 / Accepted: 21 January 2023 / Published: 25 January 2023

Round 1

Reviewer 1 Report

The authors have researched a new growing hot topic of CVD in a review that is well structured and set to an audience of academic cardiologists. Since the pandemic many efforts have been spent to further understand the implication of COVID-19 with CVDs. A part of these efforts has investigated miRNAs involvement, highlighting interesting scientific evidence. 
The article requires moderate English adjustments and there are common punctuation errors (see chapter 3 and the miRNAs following are 2.1 as they should be 3.1 etc.).

My main concern however is a missing link between chapter 3 and the conclusion. Since the authors talk about CVDs, it is fit to identify the main ones (Heart failure, VTE, Myocarditis, arterial thrombotic events, Takotsubo syndrome) with relative miRNA association. This has been done recently by other authors, you can take inspiration from them (35282650; 35779946; 35167732). This missing aspect should also be completed with a summarizing figure (you can also modify the existing one, expanding it with the required CVDs). 

Lastly, the Conclusion is missing a future prospective piece where the authors suggest what future research should embrace and towards. 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

In this review Pieri et al studied the role of SARS-CoV-2 infection on alterations of miRNAs levels related to the development of cardiovascular diseases.

 

The topic of the study is relevant but still preliminary in this field, since may 2022 many other papers have been published in this topic. There are already some comments that should be addressed:

 

-        This sentence is confusing and should be rephrased (lines 76-79): “A variety of heart-specific miRNAs regulate cardiac homeostasis and 76 have been implicated in the development developing over, several miRNAs expressed in 77 the cardiovascular system are upregulated following cardiac stress but also during long-78 term responses of the cardiovascular system to chronic injury”

 

-        Line 93 “February 2000 to May 2022” is the date correct?

 

-        Line 138: “hF” abbreviation should be corrected

 

-        Line 224: miR-145a-5p, should it be replaced by miR-146a-5p?

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

The authors have extensively modified the review according to what has been requested. The issues and the points have been addressed in an according manner. The article is now fit for publication. 

Back to TopTop